MedTrace Logo

Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin

NCT05953974 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2023-11-13

No results posted yet for this study

Summary

The investigators wish to test a diagnostic risk score for autoimmune encephalitis in case of encephalitis, previously validated by two American teams, in a retrospective analysis, according to the clinical and paraclinical data available in our database of the Reference Centre for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of Professor Honnorat for patients with NMDAr, anti LGi1, anti CASPR2, anti GABAbr and anti GAD antibodies.

Conditions

  • Autoimmune Encephalitis
  • Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)

Interventions

OTHER

Clinical score of Granillo and al.

Compare the performance of the clinical prediction score of confirmed autoimmune encephalitis according to the type of antibody isolated from the CSF.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-02-01
Completion
2023-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05953974 on ClinicalTrials.gov